+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Drug-drug interactions of non-steroidal anti-inflammatory drugs with other drugs in patients with rheumatic diseases



Drug-drug interactions of non-steroidal anti-inflammatory drugs with other drugs in patients with rheumatic diseases



Reumatologia Clinica 1(2): 116-120



To determine the prevalence of and identify drug-drug interactions (DDI) between non-steroidal anti-inflammatory drugs (NSAID) and other drugs in a prescription database of patients with rheumatic iseases. This is a cross-sectional study of a drug prescription database saving information on 35,000 individuals who benefited from a pre-paid medical system serving bank employees and their relatives. The analysis included one year period (from January to December 1998). NSAID-DDI were listed and classified into 3 levels (1: minor; 2: moderate, and 3: high health risk or death risk) according to DRUGDEX(r) as well as MEDLINE and EMBASE search. We analyzed 3,207 NSAID prescriptions (1.7±1.6 per patient) to 1,855 rheumatic patients (adults: 76.7%; geriatric: 20.2%, and pediatric: 3.0%; soft tissue rheumatism: 52%; osteoarthritis: 19%, and rheumatoid arthritis: 10%). There were 648 (20.20%) NSAID-DDI prescriptions: 594 (91.66%) corresponded to level 1; 46 (7.09%) to level 2, and 8 (1.23%) to level 3. In addition, 96 (2.99%) prescriptions included NSAID duplications. Interestingly, we found no NSAID-DDI with anticoagulants, anticonvulsants, and oral hypoglycemiants were found. The prevalence of NSAID-DDI prescriptions to 1,855 rheumatic patients was 20.20% in one year. NSAID-DDI was mostly (91.66%) level 1, and rarely (1.23%) level 3. NSAID duplications were found in 2.99%. These results provides information on the frequency of prescriptions with DDI, which might potentially produce harmful effects and data, which may help in the development of studies searching for the clinical relevance of NSAID-DDI.

(PDF emailed within 0-6 h: $19.90)

Accession: 052722331

Download citation: RISBibTeXText

PMID: 21794246

DOI: 10.1016/S1699-258X(05)72724-8


Related references

Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: An example with diuretics and non-steroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology 56(9-10): 733-738, 2000

Drug interactions with non steroidal anti-inflammatory drugs (NSAIDs). Scandinavian Journal of Rheumatology. Supplement 83: 7-10, 1989

Drug interactions between non-steroidal anti-inflammatory drugs and cardiovascular treatments (except anti-agregant therapy). Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry 12(1): 36-46, 2013

Interactions between non-steroidal anti-inflammatory drugs and biological membranes. I. High amplitude pseudo-energized mitochondrial swelling and membrane permeability changes induced by various non-steroidal anti-inflammatory drugs. Biochemical Pharmacology 22(21): 2693-2705, 1973

Interactions between non-steroidal anti-inflammatory drugs and biological membranes. II. Swelling and membrane permeability changes induced in some immunocompetent cells by various non-steroidal anti-inflammatory drugs. Biochemical Pharmacology 22(21): 2707-2717, 1973

Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2009(2): 16-21, 2009

Non steroidal anti-inflammatory drugs and rheumatic diseases. Revista do Hospital das Clinicas 50(2): 115-124, 1995

Non-steroidal anti-inflammatory drugs: use in rheumatic diseases. Journal of the Kentucky Medical Association 77(6): 285-288, 1979

Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database. Fundamental and Clinical Pharmacology 28(2): 230-235, 2014

Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole. European Journal Of Clinical Pharmacology. 54(5): 399-404, Y, 1998

Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices. Hepato-Gastroenterology 56(94-95): 1366-1370, 2009

Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis. Seminars in Arthritis and Rheumatism 45(4): 428-438, 2016

Toxic nephropathy, early diagnosis and prevention.4.Exogenous substance.1.Drug.(4).Non-steroidal anti-inflammatory drugs, and immunoregulation drugs. Nihon Naika Gakkai Zasshi 83(10): 1747-1751, 1994

The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases. British Journal of Rheumatology 32(1): 73-77, 1993

The choice of non-steroidal anti-inflammatory drugs in the rheumatic diseases. Drug and Therapeutics Bulletin 15(24): 93-95, 1977